End-of-day quote
Taipei Exchange
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
70.5
TWD
|
0.00%
|
|
-0.70%
|
-2.62%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,540
|
1,954
|
1,830
|
Enterprise Value (EV)
1 |
2,645
|
2,209
|
2,213
|
P/E ratio
|
19.8
x
|
14.6
x
|
-33.6
x
|
Yield
|
2.35%
|
3.53%
|
-
|
Capitalization / Revenue
|
3.08
x
|
2.2
x
|
2.6
x
|
EV / Revenue
|
3.21
x
|
2.49
x
|
3.15
x
|
EV / EBITDA
|
11.7
x
|
11.2
x
|
161
x
|
EV / FCF
|
24,760,556
x
|
-15,681,703
x
|
-16,773,442
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
Price to Book
|
3.77
x
|
2.59
x
|
2.26
x
|
Nbr of stocks (in thousands)
|
22,990
|
22,990
|
25,278
|
Reference price
2 |
110.5
|
85.00
|
72.40
|
Announcement Date
|
4/27/22
|
3/1/23
|
3/8/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
662.8
|
825.1
|
888.2
|
702.8
|
EBITDA
1 |
145.3
|
225.4
|
198
|
13.77
|
EBIT
1 |
81.86
|
158.1
|
123.8
|
-75.84
|
Operating Margin
|
12.35%
|
19.16%
|
13.94%
|
-10.79%
|
Earnings before Tax (EBT)
1 |
49.97
|
146.5
|
156.9
|
-73.62
|
Net income
1 |
36.48
|
129.2
|
134.9
|
-53.46
|
Net margin
|
5.5%
|
15.66%
|
15.19%
|
-7.61%
|
EPS
2 |
1.630
|
5.580
|
5.840
|
-2.157
|
Free Cash Flow
|
-
|
106.8
|
-140.8
|
-131.9
|
FCF margin
|
-
|
12.95%
|
-15.86%
|
-18.77%
|
FCF Conversion (EBITDA)
|
-
|
47.38%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
82.69%
|
-
|
-
|
Dividend per Share
2 |
1.000
|
2.600
|
3.000
|
-
|
Announcement Date
|
4/27/22
|
4/27/22
|
3/1/23
|
3/8/24
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
---|
Net sales
1 |
176.5
|
177.5
|
EBITDA
|
-
|
-
|
EBIT
1 |
-8.22
|
-4.323
|
Operating Margin
|
-4.66%
|
-2.44%
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
-
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
5/12/23
|
8/10/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
137
|
104
|
255
|
383
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9402
x
|
0.4622
x
|
1.285
x
|
27.8
x
|
Free Cash Flow
|
-
|
107
|
-141
|
-132
|
ROE (net income / shareholders' equity)
|
-
|
20.9%
|
18.9%
|
-6.84%
|
ROA (Net income/ Total Assets)
|
-
|
8.37%
|
5.82%
|
-3.28%
|
Assets
1 |
-
|
1,544
|
2,317
|
1,632
|
Book Value Per Share
2 |
25.30
|
29.30
|
32.80
|
32.00
|
Cash Flow per Share
2 |
5.400
|
8.100
|
6.420
|
6.760
|
Capex
1 |
75.4
|
67.1
|
231
|
161
|
Capex / Sales
|
11.38%
|
8.13%
|
26.04%
|
22.85%
|
Announcement Date
|
4/27/22
|
4/27/22
|
3/1/23
|
3/8/24
|
|
1st Jan change
|
Capi.
|
---|
| -2.62% | 54.63M | | +14.61% | 17.2B | | 0.00% | 6.8B | | -12.39% | 2.88B | | -11.15% | 2.72B | | -31.21% | 1.74B | | +5.00% | 1.25B | | -7.31% | 1.06B | | -6.67% | 870M | | -4.08% | 794M |
Testing Laboratories
|